APA (7th ed.) Citation

C, S., JB, P., MJ, v. R., N, H., I, V., HR, V., . . . WP, K. (2020). Diverse BRAF Gene Fusions Confer Resistance to EGFR-Targeted Therapy via Differential Modulation of BRAF Activity. Molecular cancer research : MCR, 18(4), 537. https://doi.org/10.1158/1541-7786.MCR-19-0529

Chicago Style (17th ed.) Citation

C, Stangl, et al. "Diverse BRAF Gene Fusions Confer Resistance to EGFR-Targeted Therapy via Differential Modulation of BRAF Activity." Molecular Cancer Research : MCR 18, no. 4 (2020): 537. https://doi.org/10.1158/1541-7786.MCR-19-0529.

MLA (9th ed.) Citation

C, Stangl, et al. "Diverse BRAF Gene Fusions Confer Resistance to EGFR-Targeted Therapy via Differential Modulation of BRAF Activity." Molecular Cancer Research : MCR, vol. 18, no. 4, 2020, p. 537, https://doi.org/10.1158/1541-7786.MCR-19-0529.